The latest Health Policy Brief from Health Affairs and the Robert Wood Johnson Foundation explains many of the current debates surrounding the use of specialty pharmaceuticals. Specialty pharmaceuticals—drugs and biologics used to treat chronic, serious
Read More...
Read the complete post at http://healthaffairs.org/blog/2013/11/25/recent-health-policy-briefs-specialty-pharmaceuticals-and-medicare-hospital-readmissions/?utm_source=rss&utm_medium=rss&utm_campaign=recent-health-policy-briefs-specialty-pharmaceuticals-and-medicare-hospital-readmissions
Posted
Nov 25 2013, 11:28 AM
by
Health Affairs Blog
Filed under: All Categories, Health Reform, Consumers, Policy, Payment, Chronic Care, Health Care Costs, Medicare, Access, Pharma, Hospitals, Cost, Comparative Effectiveness